
Work Here?
eVisit builds a platform that lets large health systems run their own virtual hospitals, uniting virtual and hybrid care across acute and ambulatory settings with programs like Virtual Nursing, ED Triage, and primary, urgent, and specialty care. The product is highly configurable (over 150 settings) to tailor workflows and run care through providers’ own networks, not third-party telehealth vendors. This approach improves accessibility and patient experience, reflected in about 42% higher adoption and a 5.8x ROI for customers. The goal is to scale virtual and hybrid care within existing health systems to expand access and improve outcomes without competing for the same patients.
Industries
Enterprise Software
Healthcare
Company Size
51-200
Company Stage
Series B
Total Funding
$73.2M
Headquarters
Mesa, Arizona
Founded
2013
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$73.2M
Above
Industry Average
Funded Over
5 Rounds
Industry standards
eVisit names Mags Tamilarasu chief product officer, promotes Justin Miller to COO. July 28, 2026 eVisit has expanded its executive leadership team by appointing Mags Tamilarasu as chief product officer and promoting Justin Miller to chief operating officer, moves that support the company's strategy to grow across commercial and federal healthcare while strengthening its digital care platform. The appointments come as eVisit seeks to broaden its presence beyond commercial health systems by expanding into the federal healthcare market and creating technology and operational connections between the two sectors. The company said the strategy aligns with its mission to improve access to care, noting that nearly 80% of U.S. counties qualify as healthcare deserts, affecting more than 120 million Americans. Backed by Goldman Sachs Asset Management, Texas Health Resources, MedStar Health and UPMC, eVisit provides virtual care technology to large health systems and healthcare organizations. The company believes integrating commercial healthcare innovation with the scale of federal health agencies through a shared AI-driven, secure technology platform can help address persistent care access challenges. Tamilarasu joins eVisit with nearly 30 years of experience in federal health technology. Most recently, he served as chief technical director for health at SAIC and previously spent 13 years as chief technology officer of Federal Health Solutions at Leidos, where he led technology initiatives for agencies including the Department of Health and Human Services, the Department of Veterans Affairs, the Department of Defense, the Centers for Disease Control and Prevention, the Centers for Medicare & Medicaid Services and the Food and Drug Administration. Earlier in his career, he led solution architecture efforts at Lockheed Martin. As chief product officer, Tamilarasu will oversee eVisit's product strategy and long-term technology roadmap while directing the compliance initiatives needed to deploy the company's platform across both commercial and federal healthcare environments. "Mags Tamilarasu is a visionary leader who understands that healthcare technology succeeds or fails on mission readiness and patient outcomes," CEO Sachin Agrawal said. "As we continue to build leadership in both commercial and federal health, Mags' experience architecting resilient, enterprise-grade systems will be a force multiplier." Tamilarasu said his focus will be on building technology that supports clinicians without compromising security or regulatory standards. "Great technology in healthcare has to be trusted, not just powerful," he said. "My focus is building the product and AI capabilities that support clinicians and care teams, without ever compromising on the security and compliance standards our commercial and federal customers depend on." The company also promoted Miller from senior vice president of operations and customer success to chief operating officer earlier this year. In his expanded role, he oversees engineering, operations, customer success, implementation and support, with responsibility for aligning the company's operational execution with its growth strategy. Agrawal credited Miller with strengthening the company's operational foundation as eVisit expands into new markets. "Justin's promotion set the operational foundation we needed for this next phase of growth," Agrawal said. "He continues to be the right leader to ensure our platform turns complex health data into the operational insights required to shorten time-to-care for patients and providers." Miller said scaling operations effectively will be critical as the company grows across commercial and federal healthcare. "Growth only sticks if the organization can absorb it," he said. "My focus is change management - making sure every team, process, and system at eVisit can adapt as we grow across new markets, so our customers feel the benefit of that growth rather than the disruption of it." The leadership changes underscore a broader trend in digital healthcare, where technology providers are increasingly pursuing opportunities in both commercial and government markets while developing AI-enabled platforms that meet stringent security and compliance requirements. Companies capable of serving both sectors are positioning themselves to address growing demand for virtual care solutions that improve access, streamline operations and support increasingly data-driven healthcare delivery. Headquartered in the United States, eVisit partners with several of the nation's 20 largest health systems and supports care delivery across all 50 states in facilities representing more than 35,000 hospital beds. The company has been recognized as Best in KLAS for virtual care platforms in both 2024 and 2025, reflecting customer evaluations of its technology, innovation and service.
eVisit, a digital care transformation partner for US health systems, has appointed Mags Tamilarasu as Chief Product Officer and promoted Justin Miller to Chief Operating Officer. The appointments support eVisit's strategy to build market leadership in both commercial and federal healthcare. Tamilarasu brings nearly three decades of federal health technology experience, most recently serving as Chief Technical Director, Health at SAIC. He previously spent 13 years as Chief Technology Officer of Federal Health Solutions at Leidos. Miller, promoted from SVP of Operations and Customer Success earlier this year, oversees engineering, operations, customer success, implementation, and support teams. eVisit is backed by Goldman Sachs Asset Management, Texas Health Resources, MedStar Health, and UPMC, and received the Best in KLAS award in 2024 and 2025.
eVisit has acquired UPMC’s inpatient teleconsult technology and secured investments from UPMC Enterprises and MedStar Health, adding to its $45 million Series B funding led by Goldman Sachs Asset Management. The acquisition enhances eVisit’s inpatient telehealth capabilities. UPMC’s technology, developed in 2020, has facilitated 40,000 consults with a 92% reduction in wait times. UPMC Enterprises will also provide advisory expertise, with Andrew R. Watson, MD, joining eVisit’s Clinical Advisory Board.
eVisit has acquired UPMC's inpatient teleconsult technology and secured investments from UPMC Enterprises and MedStar Health, adding to its $45 million Series B funding led by Goldman Sachs Asset Management. The acquisition enhances eVisit's inpatient telehealth capabilities. UPMC's technology, developed in 2020, has facilitated 40,000 consults with a 92% reduction in wait times. UPMC Enterprises will also provide advisory expertise, with Andrew R. Watson, MD, joining eVisit's Clinical Advisory Board.
Setting New Standard in Virtual Healthcare DeliveryDUBAI, United Arab Emirates, May 8, 2024 /PRNewswire/ -- Monstarlab Holdings Inc (TYO: 5255), Global digital transformation consultancy, and eVisit Inc., a premier provider of digital front door and virtual care capabilities, are excited to announce their new strategic partnership aimed at enhancing digital experiences in healthcare technology. This alliance marks a significant step forward in the integration of comprehensive virtual healthcare solutions with advanced digital transformation strategies.Monstarlab and eVisit will work closely to explore and develop new business opportunities that combine their strengths in technology and healthcare.Under the agreement, Monstarlab will leverage its extensive expertise in engineering and consulting to augment eVisit's robust virtual care platform. This collaboration will enable healthcare providers to deliver superior patient care through enhanced digital capabilities and innovative solutions.Monstarlab and eVisit will work closely to explore and develop new business opportunities that combine their strengths in technology and healthcare. The partnership is structured around a shared commitment to innovation and excellence, focusing on creating high-value digital experiences that cater to the evolving needs of the healthcare industry."Joining forces with eVisit supports our strategic vision to lead transformative change across industries. This collaboration is not just about technology integrations; it's about setting a new standard in healthcare delivery," commented Mark Jones, Executive Vice President and CEO of International Market at Monstarlab."Leading healthcare delivery organizations globally are at the onset of the most significant pace of digital care transformation we've ever seen. In partnering with Monstarlab, eVisit is aligning our market-leading platform capabilities with a proven, global consulting leader
Find jobs on Simplify and start your career today
Industries
Enterprise Software
Healthcare
Company Size
51-200
Company Stage
Series B
Total Funding
$73.2M
Headquarters
Mesa, Arizona
Founded
2013
Find jobs on Simplify and start your career today